Verve Therapeutics Target Price

Explore Verve Therapeutics's target price with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Share Price

$11.13

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2025-03-04	RBC Capital	$15	34.8% upside
2024-11-06	H.C. WainwrightMitchell Kapoor	$14	25.8% upside
2024-04-03	BMO CapitalKostas Biliouris	$30	169.5% upside
2022-12-15	Goldman Sachs	$13	16.8% upside

Verve Therapeutics (VERV) FAQ

Stockcircle tracks target price for Verve Therapeutics (VERV), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Verve Therapeutics's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main VERV overview so you can move from this figure to the surrounding analysis quickly.